Spectranetics Management Scuffle Outcome To Be Decided By Shareholders
This article was originally published in The Gray Sheet
Executive Summary
Former Spectranetics CEO Joseph Largey and Chief Financial Officer Paul Samek could be reinstated to their previous positions if an alternative set of directors is elected at an upcoming shareholder meeting
You may also be interested in...
Expanded CVX-300 Claims Are Spectranetics CEO’s First Order Of Business
Incoming Spectranetics President/CEO John Schulte is pledging to fulfill the company's strategic goal to expand indications for the CVX-300 excimer laser, starting with critical limb (lower leg) ischemia
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”